Walk for hypertensive and diabetic people as health promotion
This work evaluated the importance of regular walks in the daily life of hypertensive and diabetic patients in the city of Capanema - Paraná and the impacts on their physical status. Twelve volunteers from the Hiperdia program participated. A cross-sectional descriptive study with a quantitative app...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Brasil |
| Institución: | Universidade Federal de Itajubá (UNIFEI) |
| Repositorio: | Research, Society and Development |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs.pkp.sfu.ca:article/30833 |
| Acceso en línea: | https://rsdjournal.org/index.php/rsd/article/view/30833 |
| Access Level: | acceso abierto |
| Palabra clave: | Public Health Walking Hypertension Diabetes Health promotion. Salud pública Caminar Hipertensión Promoción de la salud. Saúde Pública Caminhada Hipertensão Promoção de saúde. |
| Sumario: | This work evaluated the importance of regular walks in the daily life of hypertensive and diabetic patients in the city of Capanema - Paraná and the impacts on their physical status. Twelve volunteers from the Hiperdia program participated. A cross-sectional descriptive study with a quantitative approach was carried out. The participants answered a questionnaire and anthropometric data (blood pressure, fasting glycemia, Body Mass Index and weight) were collected before and after the experimental protocol, carried out in two phases, one with monitoring for 2 months and the other without monitoring for 5 months. The results showed that regular walking acts positively in controlling blood pressure and blood glucose levels, although they were not statistically significant by the T test applied to all parameters studied. It is concluded that physical activity can be a supportive method in the maintenance of blood pressure and glycemia, which could result in improved quality of life for the individual and reduce comorbidities, besides minimizing the economic cost of the diseases. |
|---|